OPTIMA oncology project introduction

OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence) is a € 21.3 million public-private research programme that will seek to use AI to improve care for patients with prostate, breast and lung cancer.

The Public – Patient Advisory Board

The ultimate goal of OPTIMA is to find better, more personalised treatment options for patients and to ensure that they have a good quality of life. Listen to four members of the OPTIMA Public/Patient Advisory Board on their involvement in patient advocacy organisations, their cancer journeys and their hopes for future patients.

Conchi Biurrun, Spanish Breast Cancer Federation of Associations

Conchi Biurrun from the Spanish Breast Cancer Federation of Associations and member of the OPTIMA Public/Patient Advisory Board speaks about her journey as a patient with breast cancer, her involvement in the OPTIMA project and her hopes that this project will lead to better, more personalised treatment options and a better quality of life for patients.

Erik Briers, European Prostate Cancer Coalition

Erik Briers from the European Prostate Cancer Coalition and member of the OPTIMA Patient and Public Advisory Board talks about his cancer journey and how a project such as OPTIMA can help other patients to receive optimal treatment with the help of real-life evidence and guidelines.

Seamus Cotter, Irish Lung Cancer Community

Listen to Seamus Cotter from the Irish Lung Cancer Community and member of the OPTIMA Patient and Public Advisory Board on his experiences with clinical trials and the importance of giving clear information on specific treatments to patients for an informed decision.

Marjo Forsblom, Lung Cancer Europe

Marjo Forsblom from Lung Cancer Europe was a member of the OPTIMA Public/Patient Advisory Board. In this video, she explained how OPTIMA will be putting health data to good use and aims to to develop a tool that knows what’s best for a patient in a specific situation. Sadly, she passed away in October 2023. With her familiy’s blessing, we decided to keep her video here. She will be very much missed by her OPTIMA friends and colleagues.

Nadia Harbeck, LMU

Learning from real-world well-protected data to find the best therapies

Listen to Dr. Nadia Harbeck, head of of the Breast Center LMU University Hospital in Munich, explaining about big data, real-world evidence & Artificial Intelligence within the context of breast cancer treatment and research as part of the OPTIMA project.

Torsten Blum, Helios

The importance to share clinical data for a most valuable OPTIMA platform- Torsten Blum

Dr. Torsten Gerriet Blum, senior physician and pneumologist at Helios Klinikum, is explaining about the importance of data sharing, big data, real-world evidence & Artificial Intelligence within the context of lung cancer treatment and research as part of the OPTIMA project.

Michael Bussmann, Helmholtz

Using Artificial Intelligence to transform data into knowledge

Dr. Michael Bussmann, founding manager of CASUS (Center for Advanced Systems Understanding) is leading the Work Package on Artificial Intelligence knowledge base implementation within OPTIMA. In this video, learn more about how AI can bring added value within the context of oncology care as part of the OPTIMA project.

Nicolas Mottet, EAU

Improving guidelines through real-world data for better treatment

Prof. Dr. Nicolas Mottet is Head of the Urology Department at Centre Hospitalier Universitaire de Saint-Etienne and involved as a Chairman at EAU. He explains how to improve guidelines through real-world data for better treatment in the context of prostate cancer treatment and research as part of the OPTIMA project.

Andreas Kremer & Bertrand De Meulder

Making the OPTIMA platform most useful for all stakeholders

Dr. Andreas Kremer & Dr. Bertrand De Meulder are leading the task of the analysis of the platform requirements, implementation and evaluation. In this video, you can learn more about the plans for the OPTIMA platform and about the role of artificial intelligence within the context of healthcare as part of the OPTIMA project.

Dr. Pippa Powell

The involvement of the Patient and Public Advisory Board of OPTIMA

Dr. Pippa Powell, Manager at the European Lung Foundation, is creating the link between patients, and patient organisations and research stresses in this video the importance of patient involvement within the OPTIMA project.

Peter-Paul Willemse, OPTIMA

Sharing big data and real-world evidence to solve clinical questions

Dr. Peter-Paul Willemse is Assistant Professor and Medical Doctor at the Department of Urological Oncology at UMC Utrecht. Within OPTIMA, he represents the clinical community treating prostate cancer patients and explains how sharing big data and real-world evidence may help to solve clinical questions as part of the OPTIMA project.

Prof. Daniel Prieto Alhambra

Big Data in the context of healthcare

Daniel Prieto Alhambra is professor of Pharmaco- and Device Epidemiology leading the workpackage on (non) interventional study data and real-world data gathering within OPTIMA. In this video, he discusses the role of big data within the context of healthcare as part of the OPTIMA project.

Monique Roobol

Transforming guidelines into electronic decision making tools for individual patients

Monique Roobol is Professor of Decision-Making in Urology and is explaining here about the OPTIMA project and why it is important that the project is translating clinical guidelines into electronic decision support tools.

James N’Dow and Hagen Krüger

Joining forces in a PPP to find better treatments for cancer patients

Prof. Dr. James N’ Dow, Academic Coordinator and EAU Adjunct Secretary General and Dr. Hagen Krüger, Senior Medical Director at Pfizer coordinating the OPTIMA project together. Here, they give an overview on the project and are talking about the importance of collaboration between public and private partners under IMI.